PAVM.US PAVmed Inc

Healthcare Health Care Equipment & Supplies USA Stocks
1.63 USD
Close of Nov 15, 2026
1.17 12.70
Market cap
USD 13.0M
P/E
-
P/B
0.41x
ROE
-89.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PAVM.US undervalued?

Graham number

The Graham number of PAVmed Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PAVmed Inc fundamental analysis

No fundamental analysis for PAVmed Inc yet.

PAVmed Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PAVmed Inc

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection o…

Full company profile